Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-14-000074
Filing Date
2014-04-14
Accepted
2014-04-14 14:08:15
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 f10kdraftprotectvedgar3.htm 10-K 530118
2 f10kdraftprotectvedgar3002.gif GRAPHIC 858122
3 f10kdraftprotectvedgar3003.jpg GRAPHIC 37182
5 exhibit311.htm EX-31 6290
6 exhibit312.htm EX-31 6437
7 exhibit321.htm EX-32 3169
8 exhibit322.htm EX-32 3316
  Complete submission text file 0001551163-14-000074.txt   2903582

Data Files

Seq Description Document Type Size
9 prtt-20131231.xml EX-101.INS 175445
10 prtt-20131231.xsd EX-101.SCH 9370
11 prtt-20131231_cal.xml EX-101.CAL 16560
12 prtt-20131231_def.xml EX-101.DEF 17232
13 prtt-20131231_lab.xml EX-101.LAB 76119
14 prtt-20131231_pre.xml EX-101.PRE 60522
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

EIN.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54001 | Film No.: 14762154
SIC: 2834 Pharmaceutical Preparations